O

OrbiMed Portfolio holdings

AUM $3.98B
1-Year Return 13.05%
This Quarter Return
+33.33%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$6.38B
AUM Growth
+$1.02B
Cap. Flow
-$248M
Cap. Flow %
-3.88%
Top 10 Hldgs %
40.48%
Holding
147
New
18
Increased
25
Reduced
25
Closed
25

Top Buys

1
ALEC icon
Alector
ALEC
$247M
2
NBIX icon
Neurocrine Biosciences
NBIX
$118M
3
TEVA icon
Teva Pharmaceuticals
TEVA
$64M
4
AVDR
Avedro, Inc Common Stock
AVDR
$52M
5
ENDP
Endo International plc
ENDP
$49.5M

Top Sells

1
CELG
Celgene Corp
CELG
$279M
2
BIIB icon
Biogen
BIIB
$177M
3
AGN
Allergan plc
AGN
$128M
4
CVS icon
CVS Health
CVS
$52M
5
CNC icon
Centene
CNC
$48.1M

Sector Composition

1 Healthcare 96.73%
2 Financials 1.15%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
SVA
76
DELISTED
Sinovac Biotech, Ltd
SVA
$18.4M 0.28%
2,839,500
– –
SYRE icon
77
Spyre Therapeutics
SYRE
$1.03B
$17.4M 0.27%
86,621
– –
NVO icon
78
Novo Nordisk
NVO
$250B
$17.3M 0.27%
660,000
– –
DXCM icon
79
DexCom
DXCM
$31.9B
$16.5M 0.26%
554,800
– –
VRCA icon
80
Verrica Pharmaceuticals
VRCA
$48.6M
$16M 0.25%
147,973
– –
SYBX icon
81
Synlogic
SYBX
$17M
$15.4M 0.24%
135,333
– –
TAK icon
82
Takeda Pharmaceutical
TAK
$48.3B
$15.3M 0.24%
+750,000
New +$15.3M
NBRV
83
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$11.3M 0.18%
18,578
– –
CNST
84
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$11.3M 0.18%
835,842
– –
SYK icon
85
Stryker
SYK
$151B
$10.7M 0.17%
54,000
-76,200
-59% -$15.1M
SCPH icon
86
scPharmaceuticals
SCPH
$300M
$10.2M 0.16%
3,409,865
– –
ELDN icon
87
Eledon Pharmaceuticals
ELDN
$154M
$10.2M 0.16%
140,951
– –
MRSN icon
88
Mersana Therapeutics
MRSN
$34.7M
$9.95M 0.15%
+75,645
New +$9.95M
AMRN
89
Amarin Corp
AMRN
$306M
$9.71M 0.15%
23,380
+19,330
+477% +$8.03M
VRNA
90
Verona Pharma
VRNA
$9.18B
$8.13M 0.13%
1,250,396
– –
FOLD icon
91
Amicus Therapeutics
FOLD
$2.44B
$7.05M 0.11%
518,309
+195,300
+60% +$2.66M
RNAC icon
92
Cartesian Therapeutics
RNAC
$262M
$6.82M 0.11%
95,969
+43,334
+82% +$3.08M
BMRN icon
93
BioMarin Pharmaceuticals
BMRN
$10.9B
$6.8M 0.11%
76,500
– –
ADVM icon
94
Adverum Biotechnologies
ADVM
$66.7M
$6.51M 0.1%
+124,320
New +$6.51M
SPRO icon
95
Spero Therapeutics
SPRO
$119M
$6.5M 0.1%
+507,471
New +$6.5M
XENE icon
96
Xenon Pharmaceuticals
XENE
$2.97B
$6.45M 0.1%
634,812
– –
NTLA icon
97
Intellia Therapeutics
NTLA
$1.25B
$6.45M 0.1%
377,600
– –
ADAP
98
Adaptimmune Therapeutics
ADAP
$13.1M
$5.81M 0.09%
1,350,655
– –
XFOR icon
99
X4 Pharmaceuticals
XFOR
$82.6M
$5.42M 0.08%
10,383
– –
ATNX
100
DELISTED
Athenex, Inc. Common Stock
ATNX
$5.27M 0.08%
21,500
– –
2 3
4
5 6